These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6279968)

  • 41. Regression of a pregnancy-dependent mouse mammary tumor (TP-DMT-4) by the antiestrogen, tamoxifen.
    Matsuzawa A; Yamamoto T
    Gan; 1979 Jun; 70(3):387-8. PubMed ID: 467901
    [No Abstract]   [Full Text] [Related]  

  • 42. Two sex steroid receptors in SC-115 mammary tumor cells.
    Jung-Testas I; Desmond W; Baulieu EE
    Exp Cell Res; 1976 Feb; 97(2):219-32. PubMed ID: 174921
    [No Abstract]   [Full Text] [Related]  

  • 43. Hormonal influences on the expression of casein messenger RNA during mouse mammary tumorigenesis.
    Pauley RJ; Socher SH
    Cancer Res; 1980 Feb; 40(2):362-7. PubMed ID: 7356520
    [No Abstract]   [Full Text] [Related]  

  • 44. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can an autocrine loop explain sex-hormone-dependent tumor growth? A brief overview.
    Sato B
    Oncology; 1999 Oct; 57 Suppl 2():3-6. PubMed ID: 10545797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Stimulation and inhibition of the growth of sex-steroid-dependent tumors].
    Matsumoto K; Nakamura N; Sato B
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):771-9. PubMed ID: 3566289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen-dependent tumors. Overview.
    Ogata E
    Oncology; 1998 Dec; 55 Suppl 1():3-4. PubMed ID: 9935360
    [No Abstract]   [Full Text] [Related]  

  • 48. Methylcobalamin decreases mRNA levels of androgen-induced growth factor in androgen-dependent Shionogi carcinoma 115 cells.
    Nishizawa Y; Yamamoto T; Tanigaki Y; Kasugai T; Mano M; Ishiguro S; Fushiki S; Poirier LA; Nishizawa Y
    Nutr Cancer; 1999; 35(2):195-201. PubMed ID: 10693175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pregnancy-dependent to ovarian-independent progression in mammary tumors delineated in primary culture: changes in signal transduction, growth factor regulation, and matrix interaction.
    Imagawa W; Bandyopadhyay GK; Garcia M; Matsuzawa A; Nandi S
    Cancer Res; 1992 Dec; 52(23):6531-8. PubMed ID: 1330295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reviews on cancer.
    Biochim Biophys Acta; 1979 Dec; 560(4):397-529. PubMed ID: 229905
    [No Abstract]   [Full Text] [Related]  

  • 51. Androgen-Dependent transcriptional regulation of the prostate-specific antigen gene by thyroid hormone 3,5,3'-L-triiodothyronine.
    Zhu W; Young CY
    J Androl; 2001; 22(1):136-41. PubMed ID: 11191079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095.
    Szepeshazi K; Schally AV; Halmos G; Groot K; Radulovic S
    J Natl Cancer Inst; 1992 Dec; 84(24):1915-22. PubMed ID: 1460673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of adjuvant endocrine and adjuvant chemoendocrine therapies on metastasis of androgen-dependent Shionogi carcinoma 115.
    Yoshikawa T; Kitamura Y; Uchida N; Yamaguchi K; Matsumoto K
    Cancer Res; 1983 Oct; 43(10):4525-9. PubMed ID: 6883315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Androgen dependency of a tumor produced by a cell line derived from androgen-responsive Shionogi carcinoma 115.
    Terada N; Yamamoto R; Uchida N; Takada T; Taniguchi H; Takatsuka D; Sawada M; Tsuji M; Li W; Kitamura Y
    Cancer Res; 1989 Feb; 49(3):693-8. PubMed ID: 2910490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.
    Akakura K; Bruchovsky N; Goldenberg SL; Rennie PS; Buckley AR; Sullivan LD
    Cancer; 1993 May; 71(9):2782-90. PubMed ID: 7682149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.
    Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL
    Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of steroids on growth of an androgen-dependent mouse mammary carcinoma in cell culture.
    Smith JA; King RJ
    Exp Cell Res; 1972 Aug; 73(2):351-9. PubMed ID: 5066243
    [No Abstract]   [Full Text] [Related]  

  • 60. Characterization of apoptosis in prostatic androgen-independent cell lines.
    Salido M; López A; Aparicio J; Larran J; Vilches J
    Int J Dev Biol; 1996; Suppl 1():191S-192S. PubMed ID: 9087756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.